Labcorp Layers AI Across Consumer Health and Diagnostics as Growth Accelerates

Labcorp reported higher revenue and earnings in the second quarter while outlining how artificial intelligence is becoming part of its consumer health, diagnostics, and clinical research operations. From consumer health applications to clinical research services, executives described AI as one component of the company's ongoing investments in diagnostics, digital services, and laboratory workflows.

The healthcare diagnostics company reported revenue of $3.7 billion for the quarter ended June 30, up 5.8% year over year, while adjusted earnings per share increased 14.9% to $4.99. Following the results, Labcorp raised its full-year revenue and adjusted EPS guidance, citing momentum across both its Diagnostics and Biopharma Laboratory Services businesses. Official financial results are available through Labcorp's Investor Relations website and the company's earnings release.

The quarter also showed where Labcorp is investing. Specialty diagnostics contributed an increasing share of growth, while consumer healthcare became more digital. Executives described AI as supporting patient engagement, physician workflows, and laboratory operations through services the business already offers.

AI Moves Closer to the Patient

The clearest example of that strategy is in Labcorp's consumer business, where the company is using AI to simplify how patients access and interpret their health information.